Table 3 |
|||||
|
Statistical comparison of cell adhesion molecule levels among all groups |
|||||
|
Cell adhesion molecule |
Group IA (n = 15) |
Group IB (n = 20) |
Group II (n = 10) |
Group III (n = 10) |
Post hoc* |
|
|
|||||
|
sICAM-1 Baseline ng/ml |
633.37 ± 136.8 |
450.0 ± 138.9 |
196.4 ± 100.2 |
93.6 ± 43.6 |
1 > 2 > (3 = 4) |
|
sVCAM-1 Baseline ng/ml |
390.3 ± 96.9 |
283.9 ± 75.5 |
162.0 ± 52.5 |
105.0 ± 33.5 |
1 > 2 > (3 = 4) |
|
|
|||||
|
* Scheffe test Group IA: Patients with unstable angina pectoris and tirofiban infusion, Group IB: Patients with unstable angina pectoris but no tirofiban infusion, Group II: Patients with stable angina pectoris, Group III: patients with normal coronary angiography,sICAM-1: Soluble intercellular adhesion molecule-1, sVCAM-1: Soluble vascular cell adhesion molecule-1. |
|||||
|
Ercan et al. Thrombosis Journal 2004 2:4 doi:10.1186/1477-9560-2-4 |
|||||